Yinglu Zhou

613 total citations
15 papers, 152 citations indexed

About

Yinglu Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yinglu Zhou has authored 15 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Yinglu Zhou's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Prostate Cancer Treatment and Research (3 papers). Yinglu Zhou is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Prostate Cancer Treatment and Research (3 papers). Yinglu Zhou collaborates with scholars based in United States, China and Italy. Yinglu Zhou's co-authors include Huatao Li, Rongfeng Cao, Zhongling Jiang, Cong Xia, Wenru Tian, Xin Wang, Chen Gao, Dongjun Zhang, Zhao Yuan and Jing Xiao and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Microbiology.

In The Last Decade

Yinglu Zhou

13 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinglu Zhou United States 7 70 51 24 23 17 15 152
Emily S. Seltzer United States 6 60 0.9× 137 2.7× 50 2.1× 20 0.9× 38 2.2× 11 304
Shao‐Mei Huang Taiwan 9 82 1.2× 24 0.5× 15 0.6× 14 0.6× 17 1.0× 22 184
Tolulope Adeyelu United States 7 150 2.1× 15 0.3× 30 1.3× 13 0.6× 17 1.0× 25 220
Mihui Li China 13 130 1.9× 86 1.7× 26 1.1× 56 2.4× 35 2.1× 18 331
Massimo Bonucci Italy 9 92 1.3× 13 0.3× 37 1.5× 10 0.4× 14 0.8× 28 214
Haiqing Hua China 8 124 1.8× 33 0.6× 56 2.3× 17 0.7× 12 0.7× 17 245
Takanori Tatsuno Japan 11 150 2.1× 23 0.5× 11 0.5× 24 1.0× 29 1.7× 17 289
Zhi Zhao China 9 178 2.5× 23 0.5× 39 1.6× 27 1.2× 44 2.6× 35 281
Hong-Da Chen Taiwan 8 129 1.8× 60 1.2× 21 0.9× 16 0.7× 32 1.9× 20 312

Countries citing papers authored by Yinglu Zhou

Since Specialization
Citations

This map shows the geographic impact of Yinglu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinglu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinglu Zhou more than expected).

Fields of papers citing papers by Yinglu Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinglu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinglu Zhou. The network helps show where Yinglu Zhou may publish in the future.

Co-authorship network of co-authors of Yinglu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yinglu Zhou. A scholar is included among the top collaborators of Yinglu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinglu Zhou. Yinglu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhou, Yinglu, Andrea E. Wahner Hendrickson, Gini F. Fleming, et al.. (2025). A phase II trial of pembrolizumab and lenvatinib in recurrent or persistent clear cell ovarian carcinoma (NCT05296512).. Journal of Clinical Oncology. 43(16_suppl). 5515–5515.
2.
3.
4.
Zhou, Yinglu, et al.. (2024). Deciphering the role of KLRB1: a novel prognostic indicator in hepatocellular carcinoma. BMC Gastroenterology. 24(1). 210–210. 3 indexed citations
5.
Lee, Elizabeth, Yinglu Zhou, Andrea Wahner Hendrickson, et al.. (2024). LB009/#1562  A phase II trial of pembrolizumab and lenvatinib in recurrent or persistent clear cell ovarian carcinoma (NCT05296512): stage 1 results. A11–A12. 1 indexed citations
6.
Butler, William, Lingfan Xu, Yinglu Zhou, et al.. (2023). Oncofetal protein glypican‐3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer. The Journal of Pathology. 260(1). 43–55. 10 indexed citations
7.
Ryan, Christine E., Danielle M. Brander, Paul M. Barr, et al.. (2023). A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia. Leukemia. 37(4). 835–842. 2 indexed citations
8.
Butler, William, Qing Yang, Yiping He, et al.. (2023). Rewiring of the N-Glycome with prostate cancer progression and therapy resistance. npj Precision Oncology. 7(1). 22–22. 14 indexed citations
9.
Ahn, Inhye E., Yinglu Zhou, Svitlana Tyekucheva, et al.. (2023). A Phase 2 Study of Acalabrutinib, Umbralisib, and Ublituximab (AU2) in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL). Blood. 142(Supplement 1). 1914–1914.
10.
Ma, Chaoran, Yinglu Zhou, Giuseppe Nicolò Fanelli, et al.. (2022). The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer. Molecular Cancer Research. 21(3). 253–260. 6 indexed citations
11.
Zhou, Yinglu, et al.. (2021). Functional gradient alteration in individuals with cognitive vulnerability to depression. Journal of Psychiatric Research. 144. 338–344. 9 indexed citations
12.
Zhou, Yinglu, et al.. (2021). Daily hassles and depressive symptoms among COVID-19 home quarantined Chinese university students: The moderating effects of negative cognitive styles. Journal of Psychology in Africa. 31(2). 124–130. 2 indexed citations
13.
Xiao, Qian, et al.. (2019). Irrelevant emotional distractor faces and attentional capture by individuals with cognitive vulnerability to depression. Nordic Psychology. 72(2). 168–179. 2 indexed citations
14.
Gao, Chen, Yinglu Zhou, Zhongling Jiang, et al.. (2017). Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells. Oncology Reports. 38(3). 1491–1499. 49 indexed citations
15.
Zhou, Yinglu, Huatao Li, Cong Xia, et al.. (2017). Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro. Molecular Medicine Reports. 16(6). 8729–8734. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily S. Seltzer Breakdown of academic impact, for papers by Shao‐Mei Huang Breakdown of academic impact, for papers by Tolulope Adeyelu Breakdown of academic impact, for papers by Mihui Li Breakdown of academic impact, for papers by Massimo Bonucci Breakdown of academic impact, for papers by Haiqing Hua Breakdown of academic impact, for papers by Takanori Tatsuno Breakdown of academic impact, for papers by Zhi Zhao Breakdown of academic impact, for papers by Hong-Da Chen
Rankless by CCL
2026